HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Acasti Pharma Inc. (ACST)
0.7784  -0.0216  (-2.7%) 08-04 15:28
Open: 0.8 High: 0.818899
Pre.close: 0.8 Low: 0.7533
Volume: 2,834,873 Ave vol: 2,706,053
52w High: 3.08 52w Low: 0.25
MA(50): 0.678 MA(200): 0.587
EPS: -0.302 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.acastipharma.com
Market Cap (M): 68
Shares Out (M): 87
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Technical analysis
Overall: Outperform
MA: Bullish MACD: Bullish
KDJ: Bullish RSI: Bearish
Target 1: 0.97 Target 2: 1.13
Resist 1: 0.83 Resist 2: 0.97
Support 1: 0.59 Support 2: 0.44
Company key metrics
Revenue per Share: 0
Net Income per Share: 0
Cash per Share: 0.0002
Book Value per Share: 0.0002
Price to Sales: 0
Price to Book Value: 3887.8361
Earnings Yield: 0
Dividend Yield: 0
Debt to Equity: 0.7587
Debt to Assets: 0.4314
Financial analysis
Price to Book Value: Neutral
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Neutral
Price to Earnings: Neutral
Debt to Equity: Neutral
Stock Charts
Headline news
Tue, 04 Aug 2020
Acasti Pharma Inc. (NASDAQ:ACST) Is a Buzzing Hot Stock - Stocks Register

Tue, 04 Aug 2020
Acasti Pharma Inc., (NASDAQ: ACST) :: Current Valuation: - NasdaqNewsFeed

Mon, 03 Aug 2020
Acasti Pharma Inc., (NASDAQ: ACST) :: There Is Still Work To Do For - NasdaqNewsFeed

Mon, 03 Aug 2020
Investor Confidence is Rising for Acasti Pharma Inc. (NASDAQ:ACST) - The Oracle Dispatch

Fri, 31 Jul 2020
Analyst Updating Price Targets And Ratings For Acasti Pharma Inc. (ACST) - Stocks Register

Fri, 31 Jul 2020
Acasti Pharma Inc. (NASDAQ:ACST) Climbs 30.3% In 2020; Is It Attractive Enough At $0.64? - Marketing Sentinel

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.